TY - JOUR
T1 - Dual PI3K/mTOR inhibitors
T2 - Does p53 modulate response?
AU - Ekshyyan, Oleksandr
AU - Anandharaj, Arunkumar
AU - Nathan, Cherie Ann O.
PY - 2013/7/15
Y1 - 2013/7/15
N2 - Head and neck squamous cell carcinomas have multiple genetic alterations that can influence clinical response to treatment. It is important to evaluate how distinct alterations affect response to targeted agents to identify a subset of patients who can benefit from therapy, improving survival and decreasing toxicity.
AB - Head and neck squamous cell carcinomas have multiple genetic alterations that can influence clinical response to treatment. It is important to evaluate how distinct alterations affect response to targeted agents to identify a subset of patients who can benefit from therapy, improving survival and decreasing toxicity.
UR - http://www.scopus.com/inward/record.url?scp=84881185421&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84881185421&partnerID=8YFLogxK
U2 - 10.1158/1078-0432.CCR-13-1291
DO - 10.1158/1078-0432.CCR-13-1291
M3 - Article
C2 - 23741068
AN - SCOPUS:84881185421
SN - 1078-0432
VL - 19
SP - 3719
EP - 3721
JO - Clinical Cancer Research
JF - Clinical Cancer Research
IS - 14
ER -
